The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam

Archives of Pharmacal Research

Volumn 30, Issue 2, 2007, Pages 215-221

  Ki, Han Moe ^a   Choi, Hoo Kyun ^a  

^a Chosun University   (South Korea)

Author keywords

Ethanolamine; Meloxicam; Salt formation; Transdermal delivery

Indexed keywords

EID: 33947152888     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977697     Document Type: Article

References (19)

1. Agharkar, S., Lindenbaum, S., and Higuchi, T., Enhancement of solubility of drug salts by hydrophilic counterions: properties of organic salts of antimalarial drug. J. Pharm. Sci., 65, 747-749 (1976).
2. Anderson, B. D. and Conradi, R. A., Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J. Pharm. Sci., 74, 815-820 (1985)..
3. Barry, B. W., Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci., 14, 101-114 (2001).
4. Cheong, H.-A. and Choi, H.-K., Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines. Pharm. Res., 19, 1375-1380 (2002).
5. Cho, Y.-J. and Choi, H.-K., Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm., 169, 95-104 (1998).
6. Choi, H.-K. and Angello, J. T., Mathematical analysis and optimization of a flow-through diffusion cell system. Pharm. Res., 11, 595-599 (1994).
7. Fang, L., Nimajiri, S., Kobayashi, D., Ueda, H., Nakayama, K., Miyamae H., and Morimoto Y., Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines. J. Pharm. Sci., 93, 144-154 (2003).
8. Furst, Daniel E., Meloxicam: Selective COX-2 Inhibition in Clinical Practice. Seminars in Arthritis and Rheumatism. 26 (6) (SUPPL 1), 21-27 (1997).
9. Ghafourian, T., Zandasrar P., Hamishekar, H., and Nokhodchi, A., The effect of penetration enhancers on drug delivery through skin: a QSAR study. J. Control. Release, 99, 113-125 (2004).
10. Hatanaka, T., Kamon, T., Morigaki, S., Katayama, K., and Koizumi, T., Ion pair skin transport of a zwitterionic drug, cephalexin. J. Control. Release, 66, 63-71 (2000).
11. Lugar, P., Daneck, K., Engel, W., Trummlitz, G., and Wagner, K., Structure and physicochemical properties of meloxicam, a new NSAID. Eur. J. Pharm. Sci., 4, 175-187 (1996).
12. Mazzenga, G. C. and Berner, B., The transdermal delivery of zwitterionic drugs I: the solubility of zwitterion salts. J. Control. Release, 16, 77-88 (1991).
13. Mazzenga, Gerard C., Berner, B., and Jordan, F., The transdermal delivery of zwitterionic drugs II : the flux of zwitterion salts. J. Control. Release, 20, 163-170 (1992).
14. Megwa, S. A., Cross, S. E., Benson, H. A. E., and Roberts, M. S., Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. J. Pharm. Pharmacol., 52, 919-928 (2000).
15. Mihalic, M., Hofman, H., Kuftinec, J., Krile, B., Caplar, V., Kajfez, F., and Blazevic, N., Piroxicam. In: Florey, K. (Ed.), Analytical Profiles of Drug Substances, Vol. 15, Academic Press, London, pp. 509-531 (1986).
16. Narishetty, Sunil T. K. and Panchagnula, R., Effect of menthol and 1,8-cineole on phase behavior and molecular organization of zidovudine. J. Control. Release, 102, 59-70 (2005).
17. Rubino, J. T., Solubilities and solid-state properties of the sodium salts of drugs. J. Pharm. Sci., 78, 485-489 (1989).
18. Sznitowska, M., Janicki, S., and Gos, T., The effect of sorption promoters on percutaneous permeation of a model zwitterions baclofen. Int. J. Pharm., 137, 125-132 (1996).
19. Williams, Adrian C. and Barry, Brian W., Penetration enhancers. Adv. Drug Deliver. Rev., 56, 603-618 (2004).